Persistent panhypogammaglobulinemia with selected loss of memory B cells and impaired isotype expression after rituximab therapy for post-transplant EBV-associated autoimmune hemolytic anemia

Eur J Haematol. 2005 Dec;75(6):527-9. doi: 10.1111/j.1600-0609.2005.00552.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Agammaglobulinemia / blood*
  • Agammaglobulinemia / etiology
  • Anemia, Hemolytic, Autoimmune / blood*
  • Anemia, Hemolytic, Autoimmune / complications
  • Anemia, Hemolytic, Autoimmune / virology
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • B-Lymphocytes*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Epstein-Barr Virus Infections / blood*
  • Epstein-Barr Virus Infections / complications
  • Female
  • Herpesvirus 4, Human*
  • Humans
  • Immunoglobulins / blood
  • Immunologic Memory*
  • Lymphocyte Count / methods
  • Lymphoma, AIDS-Related / complications
  • Lymphoma, AIDS-Related / physiopathology
  • Lymphoma, AIDS-Related / therapy*
  • Middle Aged
  • Peripheral Blood Stem Cell Transplantation* / methods
  • Prednisone / administration & dosage
  • Rituximab
  • Transplantation, Homologous
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulins
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol